home.social

#clinicalneurology — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #clinicalneurology, aggregated by home.social.

  1. Anti-Nogo-A therapy utilizes a novel monoclonal antibody, NG101, to stimulate the regeneration of damaged spinal cord tissue. By neutralizing growth-inhibiting proteins in the central nervous system, it enables severed nerve pathways to re-establish functional connections.
    #Neuroscience #Neurobiology #ClinicalNeurology #sflorg
    sflorg.com/2026/05/ns05122601.

  2. Anti-Nogo-A therapy utilizes a novel monoclonal antibody, NG101, to stimulate the regeneration of damaged spinal cord tissue. By neutralizing growth-inhibiting proteins in the central nervous system, it enables severed nerve pathways to re-establish functional connections.
    #Neuroscience #Neurobiology #ClinicalNeurology #sflorg
    sflorg.com/2026/05/ns05122601.

  3. Anti-Nogo-A therapy utilizes a novel monoclonal antibody, NG101, to stimulate the regeneration of damaged spinal cord tissue. By neutralizing growth-inhibiting proteins in the central nervous system, it enables severed nerve pathways to re-establish functional connections.
    #Neuroscience #Neurobiology #ClinicalNeurology #sflorg
    sflorg.com/2026/05/ns05122601.

  4. Anti-Nogo-A therapy utilizes a novel monoclonal antibody, NG101, to stimulate the regeneration of damaged spinal cord tissue. By neutralizing growth-inhibiting proteins in the central nervous system, it enables severed nerve pathways to re-establish functional connections.
    #Neuroscience #Neurobiology #ClinicalNeurology #sflorg
    sflorg.com/2026/05/ns05122601.

  5. Anti-Nogo-A therapy utilizes a novel monoclonal antibody, NG101, to stimulate the regeneration of damaged spinal cord tissue. By neutralizing growth-inhibiting proteins in the central nervous system, it enables severed nerve pathways to re-establish functional connections.
    #Neuroscience #Neurobiology #ClinicalNeurology #sflorg
    sflorg.com/2026/05/ns05122601.